A bibliometric review of drug repurposing.

We have conducted a bibliometric review of drug repurposing by scanning >25 million papers in PubMed and using text-mining methods to gather, count and analyze chemical-disease therapeutic relationships. We find that >60% of the ∼35,000 drugs or drug candidates identified in our study have been tried in more than one disease, including 189 drugs that have been tried in >300 diseases each. Whereas in the majority of cases these drugs were applied in therapeutic areas close to their original use, there have been striking, and perhaps instructive, successful attempts of drug repurposing for unexpected, novel therapeutic areas.

[1]  J. Menéndez,et al.  Metabolic stress in infected cells may represent a therapeutic target for human immunodeficiency virus infection. , 2013, Medical hypotheses.

[2]  G. Chrousos,et al.  New use for old drugs? Prospective targets of chloroquines in cancer therapy. , 2014, Current drug targets.

[3]  R. Baldessarini,et al.  Neurosyphilis, Malaria, and the Discovery of Antipsychotic Agents , 2008, Harvard review of psychiatry.

[4]  M. Schlitzer,et al.  Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development , 2007, ChemMedChem.

[5]  A. H. Mackenzie.  An appraisal of chloroquine. , 1970, Arthritis and rheumatism.

[6]  P. Dongen,et al.  History of ergot alkaloids from ergotism to ergometrine , 1995 .

[7]  I. Smith,et al.  Oral glucocorticosteroids: effective in a case of restless legs syndrome resistant to other therapies. , 2010, Sleep medicine.

[8]  A. Chauhan.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent. , 2015, Microbes and infection.

[9]  C. Ripstein,et al.  Chlorpromazine (thorazine) in the treatment of intractable hiccups. , 1955, Journal of the American Medical Association.

[10]  W. G. Hardy,et al.  Effect of reserpine and chlorpromazine on sarcoma 37. , 1957, Science.

[11]  Joel Dudley,et al.  Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..

[12]  Hoyun Lee,et al.  Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. , 2009, European journal of pharmacology.

[13]  P. Hunter.  The inflammation theory of disease , 2012, EMBO reports.

[14]  B. Greenwood-Van Meerveld,et al.  A novel TRPV1 receptor antagonist JNJ-17203212 attenuates colonic hypersensitivity in rats. , 2010, Methods and findings in experimental and clinical pharmacology.

[15]  E. Cranston.  Effects of some tranquilizers on a mammary adenocarcinoma in mice. , 1958, Cancer research.

[16]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[17]  R. Fox.  Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development , 1996 .

[18]  D. Wallace.  The history of antimalarials , 1996 .

[19]  ACTIVITY of a new antimalarial agent, chloroquine (SN 7618). , 1946, Journal of the American Medical Association.

[20]  H. Ghofrani,et al.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.

[21]  Katsuhiro Kobayashi,et al.  Steroid-dependent sensorineural hearing loss in a patient with Charcot-Marie-Tooth disease showing auditory neuropathy. , 2015, Auris, nasus, larynx.

[22]  M. Gelb,et al.  Repurposing strategies for tropical disease drug discovery. , 2016, Bioorganic & medicinal chemistry letters.

[23]  C. Mulder,et al.  Finding hidden treasures in old drugs: the challenges and importance of licensing generics. , 2018, Drug discovery today.

[24]  F. López-Muñoz,et al.  History of the discovery and clinical introduction of chlorpromazine. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[25]  J. Dundee,et al.  CHLORPROMAZINE AND THE PRODUCTION OF HYPOTHERMIA , 1954, Anaesthesia.

[26]  G. Haydu.  RHEUMATOID ARTHRITIS THERAPY: A RATIONALE AND THE USE OF CHLOROQUINE DIPHOSPHATE° , 1953 .

[27]  M. Eadie.  Ergot of rye—the first specific for migraine , 2004, Journal of Clinical Neuroscience.

[28]  A. Lykkesfeldt,et al.  The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells , 2009, Anti-cancer drugs.

[29]  H. Mehlhorn,et al.  Seventy-five years of Resochin® in the fight against malaria , 2009, Parasitology Research.

[30]  A. Savarino,et al.  Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS , 2015, Retrovirology.

[31]  R. Cooper,et al.  Chloroquine: novel uses & manifestations. , 2008, The Indian journal of medical research.

[32]  Gregory McAllister,et al.  Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy , 2015, Proceedings of the National Academy of Sciences.

[33]  M. Matharu,et al.  Therapeutic effect of intranasal evaporative cooling in patients with migraine: a pilot study , 2015, The Journal of Headache and Pain.

[34]  L. Csatary.  Chlorpromazines and cancer. , 1972, Lancet.

[35]  Pan Pantziarka,et al.  The Repurposing Drugs in Oncology (ReDO) Project , 2014, Ecancermedicalscience.

[36]  J. Le bras,et al.  In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum , 1992, Antimicrobial Agents and Chemotherapy.

[37]  L. Tilley,et al.  Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. , 2002, Biochemical pharmacology.

[38]  Bradley M. Hemminger,et al.  Mining connections between chemicals, proteins, and diseases extracted from Medline annotations , 2010, J. Biomed. Informatics.

[39]  D. Wallace,et al.  The history of antimalarials. , 1996, Lupus.

[40]  R. Preston,et al.  Chloroquine diphosphate in treatment of discoid lupus erythematosus. , 1953, Journal of the American Medical Association.

[41]  F. Page.  Treatment of lupus erythematosus with mepacrine. , 1951, Lancet.

[42]  Vassilis Virvilis,et al.  Literature mining, ontologies and information visualization for drug repurposing , 2011, Briefings Bioinform..

[43]  Sean Ekins,et al.  In silico repositioning of approved drugs for rare and neglected diseases. , 2011, Drug discovery today.

[44]  Harer Wb.  Chlorpromazine in normal labor. , 1956 .

[45]  U. Reuter,et al.  Two TRPV1 receptor antagonists are effective in two different experimental models of migraine , 2015, The Journal of Headache and Pain.

[46]  V. Sukhatme,et al.  Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? , 2015, Future oncology.

[47]  D. Robertson,et al.  Chlorpromazine in the management of tetanus. , 1955, Lancet.

[48]  X. Ji,et al.  Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapy , 2015, Neurological research.

[49]  Z. Huang,et al.  Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment , 2013, Cell Death and Disease.

[50]  I. S. Levij,et al.  Antineoplastic effect of chlorpromazine in chemical carcinogenesis in the hamster cheek pouch. , 1972, Cancer research.

[51]  Cheng Zhu,et al.  Drug repositioning for orphan diseases , 2011, Briefings Bioinform..

[52]  T. Miedaner,et al.  Biology, Genetics, and Management of Ergot (Claviceps spp.) in Rye, Sorghum, and Pearl Millet , 2015, Toxins.